Back to Search
Start Over
Clinical Validation of the Cervista HPV HR Test According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Cancer Screening
- Source :
- Journal of Clinical Microbiology, 52(12), 4391-4393. AMER SOC MICROBIOLOGY
- Publication Year :
- 2014
- Publisher :
- AMER SOC MICROBIOLOGY, 2014.
-
Abstract
- This study demonstrates that both the clinical sensitivity and specificity of the Cervista HPV HR test for high-risk human papillomavirus (HPV) detection are not inferior to those of the Hybrid Capture 2 (HC2) test. The intra- and interlaboratory reproducibilities of Cervista were 92.0% (kappa, 0.83) and 90.4% (kappa, 0.80), respectively. The Cervista HPV HR test fulfills all the international HPV test requirements for cervical primary screening purposes.
- Subjects :
- Adult
Microbiology (medical)
Oncology
medicine.medical_specialty
Uterine Cervical Neoplasms
Cervical cancer screening
Sensitivity and Specificity
HYBRID CAPTURE 2
CYTOLOGY
AGE
Virology
Internal medicine
medicine
Humans
Mass Screening
ASSAY
Papillomaviridae
Human papillomavirus
Mass screening
Gynecology
biology
business.industry
Hybrid capture
Reproducibility of Results
virus diseases
HIGH-RISK HPV
WOMEN
DNA
Middle Aged
PERFORMANCE
biology.organism_classification
female genital diseases and pregnancy complications
Test (assessment)
Molecular Diagnostic Techniques
EXPERIENCE
Female
Test requirements
business
Kappa
Subjects
Details
- Language :
- English
- ISSN :
- 00951137
- Volume :
- 52
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Microbiology
- Accession number :
- edsair.doi.dedup.....df7e2cd85e95a9998fb00e31da8f7bfd